|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 43.49 USD | -0.16% |
|
+10.13% | +9.93% |
| 07-30 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 07-28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Search
No results match your criteria
- Stock Market
- Stocks
- ATRC Stock
- News AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions

















